COMPANY PROFILE // THE 014 REPORT
Turn Therapeutics Inc.
TTRX (Nasdaq) · Formerly: Global Health Solutions, Inc
Assembled from 2 government sources in 0.1 s
FLAGS · DISCLOSURE · SUMMARY
Missing or hidden
No flag from the records checked. 26 of 26 lists and sources checked came back clear (panel below).
✓ SEC filings✓ State registrationpossible match✗ LEI✗ SAM registration✗ IRS return✗ Website✗ Lobbying registration
No LEI, no SAM registration, no IRS return, no website, no lobbying registration on record.
Turn Therapeutics Inc. is an SEC-registered operating company in pharmaceutical preparations, incorporated in DE, based in Westlake Village, CA; listed as TTRX (Nasdaq).[source] It has filed 56 documents with the SEC in the last 12 months; the latest is a EFFECT, filed 2026-11-16.[source] Its largest institutional holders on 13F filings are SteelPeak Wealth, LLC, IEQ CAPITAL, LLC, DDFG, Inc (as of 2026-06-30).[source] Every list and source checked for this page came back clear (26 of 26), dated in the checks panel.[source]
- red0
- amber0
- info0
- SteelPeak Wealth, LLC$1.8M
- IEQ CAPITAL, LLC$1.7M
- DDFG, Inc$787K
- VANGUARD CAPITAL MANAGEMENT LLC$542K
- Wellington Shields & Co., LLC$480K
- MILLENNIUM MANAGEMENT LLC$442K
- BlackRock, Inc.$282K
- Bridgewater Advisors Inc.$242K
RECORD · WEB
Ask about this entity
Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).
PEOPLE · COUNSEL · LINKS
Leadership, advisers and links
Officers and directors (Forms 3, 4, 5)
- Burnam Bradley Evan · Chief Executive Officer (Director,Officer,10% owner) · latest Form 3 2025-10-07 · filing · LinkedIn search
- Chaudhary Zuraiz · See Remarks (Officer) · latest Form 4 2025-12-12 · filing · LinkedIn search
- Ghodadra Neilesh Shailesh · Chief Medical Officer (Director,Officer) · latest Form 4 2025-10-10 · filing · LinkedIn search
- Dewhurst Martin William · Director · latest Form 4 2026-02-04 · filing · LinkedIn search
- GOLDEN ARTHUR F · Director · latest Form 4 2025-11-25 · filing · LinkedIn search
- Gengos Andrew · Director · latest Form 4 2025-10-10 · filing · LinkedIn search
- Kester Kent Edward · Director · latest Form 4 2025-10-10 · filing · LinkedIn search
As reported to the SEC by the insiders themselves; SEC insider transactions data sets (Forms 3, 4, 5): 2026q1, 2025q4, 2025q3, 2025q2.
EVERY LIST AND SOURCE · DATED
Checked and clear
26 lists and sources checked: 26 CLEAR, 0 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.
EVERY IDENTIFIER · LINKED
ID crosswalk
| Identifier | Value | Record |
|---|---|---|
| SEC CIK | 0002023016 | source |
| EIN | 32-0456090 | source |
| Connecticut business IDpossible match | 887712 | record |
| Business address (SEC) | 250 NORTH WESTLAKE BLVD., WESTLAKE VILLAGE, CA, 91362 | source |
Does not exist in the records we hold: LEI, UEI, NY DOS ID, FDIC certificate.
EACH FEEDS WATCH
Dates coming up
- 2027-03-31 · in 131 days · Next 10-K due (period ended 2026-12-31; <br>Emerging growth company) (computed from the fiscal year end and filer status)
- 2027-05-15 · in 176 days · Next 10-Q due (period ended 2027-03-31; <br>Emerging growth company) (computed from the fiscal year end and filer status)
PEERS BY SIC CODE
Industry context
SIC 2834 (pharmaceutical preparations): 568 companies in our records share this code.
federal dollars
lobbying filings
SEC filings in 12 months
flags
Peers, each with its 014
- PFIZER INC · 124 SEC filings in 12 months · $25.74B federal (possible match)
- Merck & Co., Inc. · 150 SEC filings in 12 months · $13.51B federal (possible match)
- ABBOTT LABORATORIES · 118 SEC filings in 12 months · 1 flag · $2.64B federal (possible match)
- ASTRAZENECA PLC · 140 SEC filings in 12 months · $602.8M federal (possible match)
- TEVA PHARMACEUTICAL INDUSTRIES LTD · 168 SEC filings in 12 months · $77.6M federal (possible match)
- NOVARTIS AG · 34 SEC filings in 12 months · $41.9M federal (possible match)
- Spero Therapeutics, Inc. · 41 SEC filings in 12 months · 4 flags · $39.5M federal (possible match)
- Grifols SA · 18 SEC filings in 12 months · $22.5M federal (possible match)
- SCYNEXIS INC · 54 SEC filings in 12 months · 3 flags · $18.5M federal (possible match)
- Ensysce Biosciences, Inc. · 45 SEC filings in 12 months · 3 flags · $15.1M federal (possible match)
- UNITED THERAPEUTICS Corp · 454 SEC filings in 12 months · 2 flags · $6.8M federal (possible match)
- Zoetis Inc. · 144 SEC filings in 12 months · 1 flag · $6.7M federal (possible match)
ADDRESS · ZIP CODE
Location context
At the same address (3)
- SIMI VALLEY DAYS FOUNDATION · IRS-registered organization
- SIMI VALLEY COMMUNITY FOUNDATION · IRS-registered organization
EVERY SOURCE · NEWEST FIRST
One timeline
- 2026-11-16 filing EFFECT · SEC EDGAR
- 2026-11-16 filing EFFECT · SEC EDGAR
- 2026-11-16 filing 424B5 · SEC EDGAR
- 2026-11-16 filing 424B3 · SEC EDGAR
- 2026-11-10 filing 8-K items 7.01,9.01 · SEC EDGAR
- 2026-11-09 filing S-3 · SEC EDGAR
- 2026-11-09 filing S-3 · SEC EDGAR
- 2026-11-09 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-11-09 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-10-19 filing ARS · SEC EDGAR
- 2026-10-19 filing Proxy statement · SEC EDGAR
- 2026-10-07 filing 8-K items 7.01,9.01 · SEC EDGAR
- 2026-09-10 filing 8-K items 7.01,9.01 · SEC EDGAR
- 2026-09-09 filing 8-K items 7.01,9.01 · SEC EDGAR
- 2026-08-26 filing D · SEC EDGAR
- 2026-08-18 filing 8-K items 3.02 · SEC EDGAR
- 2026-08-17 filing 8-K items 7.01,9.01 · SEC EDGAR
- 2026-08-12 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-08-12 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-07-28 filing 8-K items 7.01,9.01 · SEC EDGAR
- 2026-07-07 filing 8-K items 7.01,9.01 · SEC EDGAR
- 2026-06-03 filing 8-K items 7.01,9.01 · SEC EDGAR
- 2026-06-01 filing 8-K items 7.01,9.01 · SEC EDGAR
- 2026-05-27 filing 8-K items 7.01,9.01 · SEC EDGAR
- 2026-05-19 filing 8-K items 7.01,9.01 · SEC EDGAR
- 2026-05-18 filing 8-K items 7.01,9.01 · SEC EDGAR
- 2026-05-13 filing C-TR · SEC EDGAR
- 2026-05-11 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-05-11 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-04-02 filing EFFECT · SEC EDGAR
78 earlier entries
- 2026-04-02 filing EFFECT
- 2026-03-31 filing POS AM
- 2026-03-31 filing POS AM
- 2026-03-31 filing Annual report (10-K)
- 2026-03-31 filing 8-K items 2.02,9.01
- 2026-03-24 filing 8-K items 1.01,2.03,3.02,7.01,9.01
- 2026-02-17 filing 8-K items 7.01,9.01
- 2026-02-09 filing 8-K items 7.01,9.01
- 2026-02-04 insider First Form 3/4/5 on record for Dewhurst Martin William (Director)
- 2026-01-12 filing 8-K items 7.01,9.01
- 2026-01-07 officer change 8-K items 5.02,7.01,9.01
- 2025-11-17 filing 424B3
- 2025-11-17 filing 424B3
- 2025-11-13 filing Quarterly report (10-Q)
- 2025-11-13 filing 8-K items 2.02,9.01
- 2025-11-12 filing 8-K items 7.01,9.01
- 2025-11-04 filing 8-K items 7.01,9.01
- 2025-10-30 filing 8-K items 7.01,9.01
- 2025-10-29 filing 424B5
- 2025-10-28 filing 8-K items 1.01,9.01
- 2025-10-22 filing 8-K items 7.01,9.01
- 2025-10-09 filing Registration (S-1)
- 2025-10-08 filing 424B4
- 2025-10-07 filing S-8
- 2025-10-07 filing CERT
- 2025-10-07 filing 8-A12B/A
- 2025-10-07 insider First Form 3/4/5 on record for Burnam Bradley Evan (Chief Executive Officer)
- 2025-10-07 insider First Form 3/4/5 on record for Chaudhary Zuraiz (See Remarks)
- 2025-10-07 insider First Form 3/4/5 on record for Ghodadra Neilesh Shailesh (Chief Medical Officer)
- 2025-10-07 insider First Form 3/4/5 on record for GOLDEN ARTHUR F (Director)
- 2025-10-07 insider First Form 3/4/5 on record for Gengos Andrew (Director)
- 2025-10-07 insider First Form 3/4/5 on record for Kester Kent Edward (Director)
- 2025-10-02 officer change 8-K items 1.01,3.03,5.02,5.03,9.01
- 2025-09-30 filing EFFECT
- 2025-09-30 name change Name changed from Global Health Solutions, Inc
- 2025-09-29 filing 8-A12B
- 2025-09-26 filing CORRESP
- 2025-09-24 filing CORRESP
- 2025-09-24 filing S-1/A
- 2025-09-23 filing UPLOAD
- 2025-09-22 filing 1-SA
- 2025-09-16 filing CORRESP
- 2025-09-16 filing S-1/A
- 2025-09-11 filing UPLOAD
- 2025-09-03 filing DRS
- 2025-09-02 filing Registration (S-1)
- 2025-08-29 filing CORRESP
- 2025-08-14 filing UPLOAD
- 2025-07-30 filing DRSLTR
- 2025-07-30 filing DRS/A
- 2025-06-27 filing 1-K
- 2025-06-20 filing DRS
- 2025-06-13 filing 253G2
- 2025-04-29 filing C-AR
- 2025-04-22 filing 253G2
- 2025-04-02 filing 253G2
- 2025-03-31 filing QUALIF
- 2025-03-27 filing CORRESP
- 2025-03-27 filing 1-A/A
- 2025-03-26 filing 1-A/A
- 2025-03-25 filing CORRESP
- 2025-03-25 filing 1-A/A
- 2025-03-25 filing C-U
- 2025-03-24 filing UPLOAD
- 2025-03-18 filing CORRESP
- 2025-03-18 filing 1-A/A
- 2025-03-17 filing UPLOAD
- 2025-03-06 filing CORRESP
- 2025-03-06 filing 1-A/A
- 2025-02-27 filing UPLOAD
- 2025-01-31 filing 1-A
- 2025-01-17 filing C/A
- 2024-12-18 filing C/A
- 2024-11-12 filing C-U
- 2024-10-22 filing C
- 2024-08-19 filing C/A
- 2024-07-15 filing C/A
- 2024-05-22 filing C
RENDERED FROM THIS PAGE
Relationship graph
Holders from 13F filings, subsidiaries from the GLEIF tree (by LEI), lobbying firms from LDA (possible match), agencies from USAspending, people from Forms 3/4/5, counsel from Exhibit 5.1, shared boards from Forms 3/4/5.
DATA MOTION // NEWEST FIRSTWhat changed
- 2026-11-16 (within 7 days) EFFECT filed
- 2026-11-16 (within 7 days) EFFECT filed
- 2026-11-16 (within 7 days) 424B5 filed (PROSPECTUS)
- 2026-11-16 (within 7 days) 424B3 filed (PROSPECTUS SUPPLEMENT)
- 2026-11-10 (within 30 days) 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-11-09 (within 30 days) S-3 filed (REGISTRATION STATEMENT)
- 2026-11-09 (within 30 days) S-3 filed (REGISTRATION STATEMENT)
- 2026-11-09 (within 30 days) 10-Q filed (QUARTERLY REPORT)
Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-20; the colour is also written out in words.
COUNTS FROM THIS PAGERelationships at a glance
PRICE · FILINGS · POSTS · NEWSMarket & news
- Price
- NASDAQ:TTRX The chart widget (TradingView) shows the price and the previous session's close. Seraphix publishes no price of its own.
- Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
- Financials
- Filed figures: published SEC values, each linked to its filing.
- Official posts
- Links to posts from the company's and agencies' verified accounts: not connected yet.
- News
- Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER1. Identity
2 possible matches held apart, matched by name only, not counted above; 1 record under a former name, shown apart.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| SEC CIK | 2023016 | id:sec-anchor: the SEC registrant record of this company | SEC EDGAR |
| Ticker / exchange | TTRX / Nasdaq | SEC company record: ticker and exchange as listed on the SEC company record | SEC EDGAR |
| EIN | 320456090 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0002023016 | SEC EDGAR / IRS |
| CUSIP | 90021W105 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0002023016 | SEC EDGAR |
former name (shown apart, not merged) (1)
- former nameGLOBAL HEALTH SOLUTIONS, INC. · New York corporations
AS FILED · EACH WITH ITS DATE AND FILING2. Filed figures
Key figures (annual filing)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Net income (loss) (fiscal year ended 2025-12-31) | -$3,194,080 | 2025-12-31 | 10-K, XBRL NetIncomeLoss | as filed | 2026-11-20 22:20 UTC | Report an error |
| Total assets (at 2025-12-31) | $12,162,241 | 2025-12-31 | 10-K, XBRL Assets | as filed | 2026-11-20 22:20 UTC | Report an error |
| Stockholders' equity (at 2025-12-31) | $4,686,723 | 2025-12-31 | 10-K, XBRL StockholdersEquity | as filed | 2026-11-20 22:20 UTC | Report an error |
| Cash and cash equivalents (at 2025-12-31) | $4,027,862 | 2025-12-31 | 10-K, XBRL CashAndCashEquivalentsAtCarryingValue | as filed | 2026-11-20 22:20 UTC | Report an error |
Company profile facts (SEC)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| SEC entity type | operating | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-20 22:20 UTC | Report an error |
| SIC industry | 2834 Pharmaceutical Preparations | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-20 22:20 UTC | Report an error |
| State of incorporation | DE | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-20 22:20 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-20 22:20 UTC | Report an error |
| Business address | 250 NORTH WESTLAKE BLVD., #210, WESTLAKE VILLAGE, CA, 91362 | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-20 22:20 UTC | Report an error |
| Exchanges | Nasdaq | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-20 22:20 UTC | Report an error |
Other filed values
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Operating cash flow (fiscal year ended 2025-12-31) | -$2,562,901 | 2025-12-31 | 10-K, XBRL NetCashProvidedByUsedInOperatingActivities | as filed | 2026-11-20 22:20 UTC | Report an error |
| Operating lease liabilities (at 2025-12-31) | $80,376 | 2025-12-31 | 10-K, XBRL OperatingLeaseLiability | as filed | 2026-11-20 22:20 UTC | Report an error |
| Form D total offering amount (D filed 2026-08-26) | Indefinite | 2026-08-26 | D | as filed | 2026-11-20 22:20 UTC | Report an error |
| Form D total amount sold (D filed 2026-08-26) | $1,650,000 | 2026-08-26 | D | as filed | 2026-11-20 22:20 UTC | Report an error |
| Form D industry group | Biotechnology | 2026-08-26 | D | as filed | 2026-11-20 22:20 UTC | Report an error |
| Form D revenue range | Decline to Disclose | 2026-08-26 | D | as filed | 2026-11-20 22:20 UTC | Report an error |
| Form D date of first sale | 2026-08-14 | 2026-08-26 | D | as filed | 2026-11-20 22:20 UTC | Report an error |
Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-09 · accession 0001213900-26-117186
| Item | Value | Period | Form | Filed | Accession | Retrieved | Report |
|---|---|---|---|---|---|---|---|
| Net income (loss) | -$6,230,868 | 3 months ended 2026-09-30 | 10-Q | 2026-11-09 | 0001213900-26-117186 | 2026-11-20 22:20 UTC | Report an error |
| Interest expense | $341,208 | 3 months ended 2026-09-30 | 10-Q | 2026-11-09 | 0001213900-26-117186 | 2026-11-20 22:20 UTC | Report an error |
| Cash and cash equivalents | $9,432,958 | at 2026-09-30 | 10-Q | 2026-11-09 | 0001213900-26-117186 | 2026-11-20 22:20 UTC | Report an error |
| Contract liabilities, noncurrent | $1,438,013 | at 2026-09-30 | 10-Q | 2026-11-09 | 0001213900-26-117186 | 2026-11-20 22:20 UTC | Report an error |
| Debt due in the next 12 months | $1,296,296 | at 2026-09-30 | 10-Q | 2026-11-09 | 0001213900-26-117186 | 2026-11-20 22:20 UTC | Report an error |
| Debt due in year 2 | $3,111,111 | at 2026-09-30 | 10-Q | 2026-11-09 | 0001213900-26-117186 | 2026-11-20 22:20 UTC | Report an error |
| Debt due in year 3 | $2,855,093 | at 2026-09-30 | 10-Q | 2026-11-09 | 0001213900-26-117186 | 2026-11-20 22:20 UTC | Report an error |
Values as filed in XBRL (SEC company facts); quarterly values are the filer's own 3-month figures, never derived.
No estimates: every value is as filed and links to the filing it came from.
Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.
NEWEST FIRST · EACH LINKS TO ITS FILING3. Registration and filing timeline
- 2026-11-16 Filing EFFECT filed
- 2026-11-16 Filing EFFECT filed
- 2026-11-16 Filing 424B5 filed (PROSPECTUS)
- 2026-11-16 Filing 424B3 filed (PROSPECTUS SUPPLEMENT)
- 2026-11-10 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-11-09 Filing S-3 filed (REGISTRATION STATEMENT)
- 2026-11-09 Filing S-3 filed (REGISTRATION STATEMENT)
- 2026-11-09 Filing 10-Q filed (QUARTERLY REPORT)
- 2026-11-09 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-10-19 Filing ARS filed
- 2026-10-19 Filing DEF 14A filed (PROXY STATEMENT)
- 2026-10-07 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-09-10 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-09-09 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-08-26 Filing D filed
- 2026-08-18 Filing 8-K filed: Item 3.02 unregistered equity sale
- 2026-08-17 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-08-12 Filing 10-Q filed (QUARTERLY REPORT)
- 2026-08-12 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-07-28 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-07-07 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-06-03 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-06-01 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-05-27 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-05-19 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
AS FILED · LARGEST HOLDERS10. 13F institutional holders
| Rank | Holder (13F filer) | Value held | As of | Source | Retrieved | Report |
|---|---|---|---|---|---|---|
| 1 | SteelPeak Wealth, LLC | $1,821,029 | 2026-06-30 | SEC 13F filing | 2026-11-20 22:20 UTC | Report an error |
| 2 | IEQ CAPITAL, LLC | $1,659,991 | 2026-06-30 | SEC 13F filing | 2026-11-20 22:20 UTC | Report an error |
| 3 | DDFG, Inc | $787,154 | 2026-06-30 | SEC 13F filing | 2026-11-20 22:20 UTC | Report an error |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | $542,397 | 2026-06-30 | SEC 13F filing | 2026-11-20 22:20 UTC | Report an error |
| 5 | Wellington Shields & Co., LLC | $479,844 | 2026-06-30 | SEC 13F filing | 2026-11-20 22:20 UTC | Report an error |
| 6 | MILLENNIUM MANAGEMENT LLC | $442,022 | 2026-06-30 | SEC 13F filing | 2026-11-20 22:20 UTC | Report an error |
| 7 | BlackRock, Inc. | $281,715 | 2026-06-30 | SEC 13F filing | 2026-11-20 22:20 UTC | Report an error |
| 8 | Bridgewater Advisors Inc. | $241,562 | 2026-06-30 | SEC 13F filing | 2026-11-20 22:20 UTC | Report an error |
| 9 | Aaron Wealth Advisors LLC | $237,717 | 2026-06-30 | SEC 13F filing | 2026-11-20 22:20 UTC | Report an error |
| 10 | Tamar Securities, LLC | $219,000 | 2026-06-30 | SEC 13F filing | 2026-11-20 22:20 UTC | Report an error |
13F as filed: the holder's own report of its position value at the quarter end.
POSSIBLE MATCHES · LICENCES, PERMITS, CITY AND STATE RECORDS13. Permits and local records
2 state and city records carry this company's exact name, from 2 sources. Possible matches only.
Connecticut business registrations (1)
possible match: matched by name only, not merged (1)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchGLOBAL HEALTH SOLUTIONS, LLC · name equals 'Global Health Solutions' but other unrelated entities share it · sx:ctsos:887712 Compare
ClinicalTrials.gov (1)
possible match: matched by name only, not merged (1)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchTurn Therapeutics · exact name match to 'Turn Therapeutics Inc.' (no other entity shares the name) · sx:ctgov:h226a7587e72e3726 Compare
WHAT THIS PAGE READ
Sources
JSON · MCP · API
API and agents
The same profile as JSON: GET /company/2023016.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0002023016. Every source URL used is listed in the file.
Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.